2022
DOI: 10.1016/j.repc.2021.07.016
|View full text |Cite
|
Sign up to set email alerts
|

The effect of paclitaxel plus carboplatin chemotherapy on subclinical cardiotoxicity in patients with non-small cell lung cancer: A speckle tracking echocardiography-based study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Indeed, a significant difference in treatment effects was observed in both Car and Car/H-dot treated groups (* p < 0.05; Figure 4c,d). Several adverse effects of Car have been reported, such as bone marrow suppression [36], ototoxicity [37], and cardiotoxicity [38][39][40] in both single and combination therapy with other drugs. In particular, the cardiotoxicity of Car proved to be fatal, causing apoptotic cell deaths and loss of cardiac fibril, significantly reducing mice survival rate [38].…”
Section: Systemic Toxicity Evaluation Of Car and Car/h-dot Complexmentioning
confidence: 99%
“…Indeed, a significant difference in treatment effects was observed in both Car and Car/H-dot treated groups (* p < 0.05; Figure 4c,d). Several adverse effects of Car have been reported, such as bone marrow suppression [36], ototoxicity [37], and cardiotoxicity [38][39][40] in both single and combination therapy with other drugs. In particular, the cardiotoxicity of Car proved to be fatal, causing apoptotic cell deaths and loss of cardiac fibril, significantly reducing mice survival rate [38].…”
Section: Systemic Toxicity Evaluation Of Car and Car/h-dot Complexmentioning
confidence: 99%